The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.
PLASMA by Yayati brings Wall Street’s most powerful tool — options — to every investor (and their advisor), with AI-powered automation built for investing your real wealth, not trading monopoly money. We turn complex options into set-it-and-forget-it strategies that work with the stocks you already own — to generate income, protect downside, and grow tax-smart
Incregen is raising $3M to complete FDA requirements to enable the launch of (Phase 1) human trials, paving the way for $30M Series A. With a seasoned team & de-risked operational plan, this is a compelling opportunity to enter the rapidly growing obesity market with strong potential for near-term exit.
Imagine a world without diabetes. Paulex Bio stands on the threshold of what could be a transformative breakthrough for Type 1 and Type 2 diabetes: an oral medicine designed to stimulate the regeneration of human beta cells to restore natural insulin production and potentially offer insulin independence to patients across the diabetes spectrum.